Sirtex
Sirtex Medical Limited is a medical device company, providing a radioactive treatment for inoperable liver cancer called SIR-Spheres microspheres. Sirtex was established in 1997 in Australia and currently maintains offices and manufacturing facilities in the U.S., Australia, Germany and Singapore. Following an acquisition by China Grand Pharmaceutical and CDH Genetech, Sirtex de-listed from the Australian Securities Exchange (ASX:SRX) on Monday, September 24, 2018. The company is currently headed by Kevin R. Smith, who was appointed as CEO on October 16, 2019.
Link from a Wikipage to another Wikipage
primaryTopic
Sirtex
Sirtex Medical Limited is a medical device company, providing a radioactive treatment for inoperable liver cancer called SIR-Spheres microspheres. Sirtex was established in 1997 in Australia and currently maintains offices and manufacturing facilities in the U.S., Australia, Germany and Singapore. Following an acquisition by China Grand Pharmaceutical and CDH Genetech, Sirtex de-listed from the Australian Securities Exchange (ASX:SRX) on Monday, September 24, 2018. The company is currently headed by Kevin R. Smith, who was appointed as CEO on October 16, 2019.
has abstract
Sirtex Medical Limited is a me ...... ed as CEO on October 16, 2019.
@en
founding year
number of employees
Link from a Wikipage to an external page
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
1,013,990,209
Link from a Wikipage to another Wikipage
foundation
homepage
Location
Woburn, MA
@en
logo
@en
name
Sirtex Medical Limited
@en
num employees
owner
China Grand Pharmaceutical and Healthcare Holdings Ltd./CDH Genetech, Ltd.
@en
products
SIR-Spheres yttrium-90 resin microspheres
@en
type
Private
@en
wikiPageUsesTemplate
subject
hypernym
comment
Sirtex Medical Limited is a me ...... ed as CEO on October 16, 2019.
@en
label
Sirtex
@en
closeMatch
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Sirtex Medical Limited
@en